Flerie AB Cuts NAV by SEK 2.66/Share After Empros Write-Down
Flerie AB (publ) wrote down its holding in Empros Pharma, reducing Flerie’s NAV by SEK 2.66 per share, citing limited likelihood of value realization.
Flerie AB (publ) wrote down its holding in Empros Pharma, reducing Flerie’s NAV by SEK 2.66 per share, citing limited likelihood of value realization.